WaveMan · Form 4
Fu Tao insider trades
> Search tickers & screens ⌘K
LIVE

Fu Tao insider trades

Fu Tao has filed 8 Form 4s with the SEC that we hold, for Zai Lab Ltd (ZLAB) (President & COO, Director) and Attovia Therapeutics, Inc. (ATTO) (President and CEO, Director). Across all of them we count 0 purchases worth $0 and 27 sales worth $7.6M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 7,935 shares of Zai Lab Ltd worth $834.2K, dated 2021-10-28. The first filing on our record is dated 2021-07-19 and the latest 2026-10-08.

Zai Lab Ltd (ZLAB)

President & COO, Director · 7 filings · 27 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-07-15S, sale reported on Form 421$3.6K2021-07-19
2021-07-15S, sale reported on Form 41,000$171.4K2021-07-19
2021-07-15S, sale reported on Form 43,281$569.5K2021-07-19
2021-07-15S, sale reported on Form 42,333$397.3K2021-07-19
2021-07-15S, sale reported on Form 4100$17.5K2021-07-19
2021-07-15S, sale reported on Form 43,265$569.0K2021-07-19
2021-08-25S, sale reported on Form 4200$28.9K2021-08-26
2021-08-25S, sale reported on Form 43,894$559.8K2021-08-26
2021-08-25S, sale reported on Form 44,306$614.5K2021-08-26
2021-08-25S, sale reported on Form 41,600$227.1K2021-08-26
2021-09-15S, sale reported on Form 4100$13.4K2021-09-27
2021-09-15S, sale reported on Form 41,300$171.9K2021-09-16
2021-09-15S, sale reported on Form 41,978$247.2K2021-09-16
2021-09-15S, sale reported on Form 43,100$390.5K2021-09-16
2021-09-15S, sale reported on Form 41,541$197.8K2021-09-16
2021-09-15S, sale reported on Form 41,007$130.2K2021-09-16
2021-09-15S, sale reported on Form 4400$53.2K2021-09-16
2021-09-15S, sale reported on Form 4574$75.0K2021-09-16
2021-09-30S, sale reported on Form 4250$27.2K2021-10-01
2021-09-30S, sale reported on Form 44,619$493.0K2021-10-01
2021-09-30S, sale reported on Form 42,714$286.5K2021-10-01
2021-09-30S, sale reported on Form 42,417$260.7K2021-10-01
2021-10-14S, sale reported on Form 45,240$539.2K2021-10-14
2021-10-14S, sale reported on Form 43,360$342.8K2021-10-14
2021-10-14S, sale reported on Form 41,400$144.8K2021-10-14
2021-10-28S, sale reported on Form 47,935$834.2K2021-10-29
2021-10-28S, sale reported on Form 42,065$215.8K2021-10-29

Attovia Therapeutics, Inc. (ATTO)

President and CEO, Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1644888) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms